HomeAI · summaries
Storia in 3 fonti
Novo Nordisk cuts semaglutide price by 15% with official Ozempic copy
Cheaper diabetes drug arrives, but Discovery sees little reason to widen patient cover
Confronto fonti
3 prospettive sulla stessa storiaTimeline cronologica
- ·
africa.businessinsider.com
Africa’s most developed pharmaceutical market reviews 12 Ozempic generics as drugmakers target Novo Nordisk’s dominance
South Africa is reviewing 12 generic semaglutide applications after Novo Nordisk’s patent expired, opening a price battle over Ozempic and Africa’s fast-growing GLP-1 market
- ·
iol.co.za
Beyond the weight-loss trend: Lower-cost semaglutide is coming to South Africa
Novo Nordisk South Africa is set to launch an authorised, more affordable version of semaglutide, aimed at improving access for type 2 diabetes patients.
